News & Updates

Show Multimedia Only

Tirzepatide improves cardiometabolic markers in Chinese adults

15 Jul 2025

Early weight loss associated with the use of tirzepatide may significantly improve cardiometabolic health, particularly in adults achieving a normal BMI by week 52, according to a China study.

Tirzepatide improves cardiometabolic markers in Chinese adults

15 Jul 2025

Expert insights on COVID-19: From vaccination to treatment

15 Jul 2025

Even in 2025, COVID-19 remains a significant global health concern. At a Pfizer-sponsored series of integrated symposia held during the ESCMID Global Congress in Vienna, Austria, leading experts presented the latest data and real-world experiences spanning the COVID-19 care continuum—from vaccination strategies to early antiviral treatment.

Expert insights on COVID-19: From vaccination to treatment

15 Jul 2025

First Chinese-specific T1D genetic risk scoring tool signifies a leap forward in correct diabetes diagnosis

15 Jul 2025 by

The first type 1 diabetes (T1D) genetic risk score (GRS) tailored for the Chinese population, developed by a joint research team from The Chinese University of Hong Kong’s (CUHK), the UK and China, signifies a leap forward in correct diagnosis of diabetes.

First Chinese-specific T1D genetic risk scoring tool signifies a leap forward in correct diabetes diagnosis

15 Jul 2025

Ecnoglutide trims weight in adults with obesity

14 Jul 2025 by

Once-a-week treatment with ecnoglutide demonstrates superiority over placebo, with sustained reductions in body weight and improvements in cardiometabolic indexes among adults with overweight or obesity, reports a study presented at ADA 2025.

Ecnoglutide trims weight in adults with obesity

14 Jul 2025

Nonproliferative may progress to proliferative DR after cataract surgery

14 Jul 2025

Patients with type 2 diabetes (T2D) and nonproliferative diabetic retinopathy (NPDR) who undergo modern cataract surgery tend to progress to proliferative diabetic retinopathy (PDR) within a year after the procedure, reveals a recent study.

Nonproliferative may progress to proliferative DR after cataract surgery

14 Jul 2025

Low-fat vegan diet’s alkalizing effect linked to greater weight loss

12 Jul 2025 by

A low-fat vegan diet yields a significant reduction in dietary acid load compared with the Mediterranean diet, and this alkalizing effect is associated with weight loss in overweight adults, according to the results of a cross-over study.

Low-fat vegan diet’s alkalizing effect linked to greater weight loss

12 Jul 2025

How GPs can bridge the gap in CKD care

12 Jul 2025

The burden of chronic kidney disease (CKD) is expected to increase in Singapore over the coming decades. Alongside this, there will be a subsequent rise in comorbidities in this population, including COVID-19 and its complications. At the recent Family Medicine Review Course 2025 supported by Pfizer, Dr Behram Ali Khan, Senior Consultant Nephrologist and Adjunct Assistant Professor of Medicine, Renal Health Services (RHS), highlighted the role of general practitioners (GPs) in curbing the increasing prevalence of CKD in Singapore, including improving the uptake of updated COVID-19 vaccinations to prevent additional comorbidities in this population.

How GPs can bridge the gap in CKD care

12 Jul 2025

Semaglutide significantly reduced the risk of MACE by 20% in individuals with CVD + obesity

11 Jul 2025

In the large multicentre, double-blind, placebo-controlled SELECT trial, semaglutide 2.4 mg significantly reduced the risk of major adverse cardiovascular events (MACE) by 20 percent in individuals with cardiovascular disease (CVD) and obesity. The MACE curves separated early before maximal weight loss, suggesting CV benefits beyond weight reduction.

Semaglutide significantly reduced the risk of MACE by 20% in individuals with CVD + obesity

11 Jul 2025

Investigational triple–hormone-receptor agonist reduces fat mass in people with T2D

10 Jul 2025

Treatment with retatrutide—an agonist of the glucose-dependent insulinotropic polypeptide, glucagon-like peptide 1, and glucagon receptors—appears to result in greater total body fat mass reduction in individuals with type 2 diabetes (T2D) and high BMI when compared with placebo and dulaglutide, according to a substudy of a phase II trial.

Investigational triple–hormone-receptor agonist reduces fat mass in people with T2D

10 Jul 2025

Malays most referred patients to nephrology care in SG

09 Jul 2025 by

A Singapore study has found that patients referred for kidney disease are predominantly Malays, who tend to have higher metabolic disease burden, miss their appointments, and be referred at lower estimated glomerular filtration rate (eGFR).

Malays most referred patients to nephrology care in SG

09 Jul 2025

News & Updates

Filter by Specialty:

Specialty:

Tirzepatide improves cardiometabolic markers in Chinese adults

Tirzepatide improves cardiometabolic markers in Chinese adults

Expert insights on COVID-19: From vaccination to treatment

Expert insights on COVID-19: From vaccination to treatment

First Chinese-specific T1D genetic risk scoring tool signifies a leap forward in correct diabetes diagnosis

First Chinese-specific T1D genetic risk scoring tool signifies a leap forward in correct diabetes diagnosis

Ecnoglutide trims weight in adults with obesity

Ecnoglutide trims weight in adults with obesity

Nonproliferative may progress to proliferative DR after cataract surgery

Nonproliferative may progress to proliferative DR after cataract surgery

Low-fat vegan diet’s alkalizing effect linked to greater weight loss

Low-fat vegan diet’s alkalizing effect linked to greater weight loss

How GPs can bridge the gap in CKD care

How GPs can bridge the gap in CKD care

Semaglutide significantly reduced the risk of MACE by 20% in individuals with CVD + obesity

Semaglutide significantly reduced the risk of MACE by 20% in individuals with CVD + obesity

Investigational triple–hormone-receptor agonist reduces fat mass in people with T2D

Investigational triple–hormone-receptor agonist reduces fat mass in people with T2D

Malays most referred patients to nephrology care in SG

Malays most referred patients to nephrology care in SG